Maha Othman and Marc Carrier
May 10, 2025, 06:35
Maha Othman: Pleasure to Interview the Brilliant Dr. Marc Carrier at Our Latest Thrombosis Canada Clot Conversation Podcast
Professor Maha Othman, Co-Chairman SSC on Disseminated intravascular coagulopathy at International Society on Thrombosis and Haemostasis, shared a post on X:
“Pleasure to interview the brilliant Dr. Marc Carrier at our latest Thrombosis Canada clot conversation podcast. Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose; preventing recurrent VTE in cancer patients while resulting in less bleeding.”
Quoting Thrombosis Canada‘s post:
“New study, new standard? Reduced-dose apixaban may change the game in cancer-associated thrombosis. Dr. Carrier explains why.
Listen here.”
Find more on Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation